p. 1−2
2476-5856
Vol.1/No.1
p. 3−9
2476-5856
Vol.1/No.1
p. 11−16
2476-5856
Vol.1/No.1
-1. A 10-year probability of hip fracture of more than 3% was detected in only in six women (1.6%) and a major osteoporotic fracture risk (of higher than 20%) was not detected in any subject. Applying FRAX in osteopenic and osteoporotic Iranian women showed no extra benefit in comparison to using BMD alone. It seems that FRAX is not accurate in our population as it underestimates the number of patients that could benefit from osteoporosis treatment.]]>
p. 17−21
2476-5856
Vol.1/No.1
p. 23−26
2476-5856
Vol.1/No.1
p. 27−32
2476-5856
Vol.1/No.1
p. 33−35
2476-5856
Vol.1/No.1
p. 37−42
2476-5856
Vol.1/No.1
p. 43−50
2476-5856
Vol.1/No.1